Pharma Packager Gets FDA Warning

According to a PharmTech.com article, the FDA issued a warning letter to Ohio-based GenPak Solutions, citing “several current good manufacturing practice (CGMP) violations, unapproved new drug violations, and misbranding violations.” The FDA inspection took place in August of 2015, but the warning wasn’t administered until June 12^th

After the inspection, the FDA determined that GenPak was repackaging, relabeling, and distributing new unapproved drugs. According to the article, the FDA found nearly 100 different misbranded products during the inspection.